Keywords: remicade, gets, ec, ok, pediatric, cd, usa-based
Remicade gets EC OK for pediatric CD
Article | 18 June 2007
USA-based drugmakers Centocor and Schering-Plough say that the European Commission has cleared their co-developed tumor necrosis factor inhibitor Remicade (infliximab) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
